Ticker League

AstraZeneca (AZN) Profit Bridge

See what drove AstraZeneca's net income from TTM through Q1 2025 to TTM through Q1 2026 — every line ranked by dollar impact, from revenue gains to taxes.

Revenue YoY

+9.93%

Operating Income YoY

+35.53%

Net Income YoY

+33.70%

Net Margin Δ

+306 bps

Net income bridge for AstraZeneca (AZN) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Net income: $2.62B+33.70%

Profit bridge breakdown for AstraZeneca (AZN) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Net Income$7.77B
  • Revenue$5.46B
  • Cost of Revenue−$840.00M
  • Operating Expenses−$864.00M
  • Other Income / Expense−$132.00M
  • Income Tax−$1.01B
  • Net Income$10.39B
Identity residual: $6.00M (delta between driver sum and reported ΔNI)
Want the full P&L structure?Income Statement Waterfall

Frequently asked questions

Data & methodology